Early detection cuts prostate cancer death risk by up to 50%: The life-saving power of PSA testing

Early detection of prostate cancer through screening—particularly via the PSA (Prostate-Specific Antigen) blood test—can reduce the risk of death by up to 50 percent, the article argues, and highlights that prostate cancer remains one of the most common cancers in men globally; it describes how PSA testing enables diagnosis at early stages (when treatment is more effective), notes that awareness of symptoms and screening guidelines is low, emphasizes the importance of raising public consciousness about who should get tested (especially men at higher risk), and urges integrating PSA screening into preventive health care for men.
*This news was published by Times of India on October 13, 2025.*

 

 

 

Source Click